The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sukiennicki, T. L.
Right arrow Articles by Fowell, D. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sukiennicki, T. L.
Right arrow Articles by Fowell, D. J.
The Journal of Immunology, 2006, 177: 6952-6961.
Copyright © 2006 by The American Association of Immunologists, Inc.

Distinct Molecular Program Imposed on CD4+ T Cell Targets by CD4+CD25+ Regulatory T Cells1

Teresa L. Sukiennicki and Deborah J. Fowell2

Department of Microbiology and Immunology, David H. Smith Center for Vaccine Biology and Immunology, Aab Institute of Biomedical Sciences, University of Rochester, Rochester, NY 14642

CD4+CD25+ regulatory T cells (Tregs) are key modulators of immunity, but their mechanism of action is unclear. To elucidate the molecular consequences of Treg encounter, we analyzed changes in gene expression in CD4+ T cell targets activated in the presence or absence of CD4+CD25+ Tregs. Tregs did not alter the early activation program of CD4+ T cells, but had reversed many of the activation-induced changes by 36 h. It is not known whether Tregs simply induce a set of transcriptional changes common to other nonproliferative states or whether instead Tregs mediate a distinct biological activity. Therefore, we compared the gene profile of T cells following Treg encounter with that of T cells made anergic, TGF-β-treated, or IL-2-deprived; all possible modes of Treg action. Strikingly, all genes down-regulated in suppressed cells were indeed common to these nonproliferative states. In contrast, Treg encounter led to elevated expression of a unique set of genes in the target T cells. Although different from the nonproliferative states tested, the Treg-imposed gene program is exemplified by expression of many genes associated with growth arrest or inhibition of proliferation. We suggest that Tregs function by the induction of a distinct set of negative regulatory factors that initiate or maintain target T cells in a nonproliferative state.

The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1 This work was supported by the Juvenile Diabetes Research Foundation, Research Grant 1-2000-609 (to D.J.F.) and National Institutes of Health Training Grant AI-07169 (to T.L.S.).

2 Address correspondence and reprint requests to Dr. Deborah J. Fowell, David H. Smith Center for Vaccine Biology and Immunology, Aab Institute of Biomedical Sciences, Department of Microbiology and Immunology, University of Rochester, 601 Elmwood Avenue, Box 609, Rochester, NY 14642. E-mail address: deborah_fowell{at}urmc.rochester.edu

3 Abbreviations used in this paper: Treg, regulatory T cell; 7-AAD, 7-aminoactinomycin D; KLF, Kruppel family; GRP1, general receptor of phosphoinositide 1.




This article has been cited by other articles:


Home page
J. Leukoc. Biol.Home page
Y.-H. Huang, A. L. Zozulya, C. Weidenfeller, N. Schwab, and H. Wiendl
T cell suppression by naturally occurring HLA-G-expressing regulatory CD4+ T cells is IL-10-dependent and reversible
J. Leukoc. Biol., August 1, 2009; 86(2): 273 - 281.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. L. Szymczak-Workman, C. J. Workman, and D. A. A. Vignali
Cutting Edge: Regulatory T Cells Do Not Require Stimulation through Their TCR to Suppress
J. Immunol., May 1, 2009; 182(9): 5188 - 5192.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
R. H. Friedline, D. S. Brown, H. Nguyen, H. Kornfeld, J. Lee, Y. Zhang, M. Appleby, S. D. Der, J. Kang, and C. A. Chambers
CD4+ regulatory T cells require CTLA-4 for the maintenance of systemic tolerance
J. Exp. Med., February 16, 2009; 206(2): 421 - 434.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
A. Giorgini and A. Noble
Blockade of chronic graft-versus-host disease by alloantigen-induced CD4+CD25+Foxp3+ regulatory T cells in nonlymphopenic hosts
J. Leukoc. Biol., November 1, 2007; 82(5): 1053 - 1061.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
N. Oberle, N. Eberhardt, C. S. Falk, P. H. Krammer, and E. Suri-Payer
Rapid Suppression of Cytokine Transcription in Human CD4+CD25 T Cells by CD4+Foxp3+ Regulatory T Cells: Independence of IL-2 Consumption, TGF-beta, and Various Inhibitors of TCR Signaling
J. Immunol., September 15, 2007; 179(6): 3578 - 3587.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2006 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2006 by The American Association of Immunologists, Inc. All rights reserved.